Hospital
Henry Ford Wyandotte Hospital
Henry Ford Wyandotte Hospital was paid $60.54M by Medicaid between Jan 2018 and Dec 2024, across 330 billing codes. Its largest line is 99285, emergency room visit (most serious) — 33% of everything it billed.
33Billing provider infoHENRY FORD WYANDOTTE HOSPITAL
WYANDOTTE, MI 48192
WYANDOTTE, MI 48192
33aNPI1992725352assigned 07/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$60.54M
24GClaims1,468,158
24DCodes billed330
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Michigan
Rank by total paid#18 of 86
Median peer was paid$21.55M
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAMSCHRODER, ROBIN controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 191,854 | $8.43M | |
| 2019 | 200,136 | $7.78M | |
| 2020 | 167,725 | $6.53M | |
| 2021 | 216,224 | $8.02M | |
| 2022 | 250,069 | $9.93M | |
| 2023 | 248,781 | $10.56M | |
| 2024incomplete | 193,369 | $9.29M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 33% | 63,350 | 58,460 | $19.86M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 39,637 | 37,833 | $6.79M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.6% | 50,539 | 48,574 | $5.81M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.3% | 39,471 | 36,723 | $3.84M |
| G0378 | Hospital observation service, per hour | 4.2% | 10,276 | 9,105 | $2.56M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.3% | 27,782 | 26,464 | $2.01M |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.8% | 34,990 | 30,559 | $1.67M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 9,763 | 9,547 | $1.39M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.1% | 18,272 | 14,317 | $1.27M |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.9% | 2,497 | 2,461 | $1.15M |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.7% | 9,454 | 9,228 | $1.04M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 12,394 | 12,178 | $890K |
318 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 8,304 | $781K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 28,551 | $772K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 7,390 | $695K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 17,550 | $673K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 17,948 | $598K |
| 59025 | Fetal non-stress test | <1% | 6,393 | $563K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 3,467 | $421K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 3,678 | $381K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 999 | $361K |
| 80061 | Lipid panel | <1% | 7,366 | $338K |
| 76830 | Ultrasound, transvaginal | <1% | 5,118 | $290K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 5,587 | $271K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 4,041 | $248K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 10,759 | $246K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 30,718 | $223K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 3,652 | $221K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 2,315 | $219K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 9,537 | $216K |
| 76801 | <1% | 3,298 | $197K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,622 | $176K |
| 93975 | <1% | 1,522 | $171K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 723 | $166K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 3,108 | $156K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,617 | $151K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 3,202 | $144K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,233 | $127K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 1,283 | $126K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 5,175 | $117K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,561 | $115K |
| 70496 | <1% | 1,567 | $113K | |
| 47562 | <1% | 42 | $109K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 8,084 | $104K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 7,968 | $97K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,005 | $92K |
| 93971 | <1% | 1,732 | $92K | |
| 76770 | <1% | 1,548 | $91K | |
| 10060 | <1% | 991 | $91K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 3,442 | $90K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 603 | $90K |
| 72141 | <1% | 626 | $85K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 4,030 | $84K |
| 93970 | <1% | 923 | $79K | |
| 97161 | <1% | 1,345 | $75K | |
| 80053 | Comprehensive metabolic panel | <1% | 44,239 | $68K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 148 | $65K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12,867 | $63K |
| 76642 | <1% | 1,423 | $58K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 351 | $50K |
| 97162 | <1% | 940 | $49K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 85,133 | $48K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,024 | $45K |
| 86900 | <1% | 8,139 | $44K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,411 | $44K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 11,589 | $41K |
| 70491 | <1% | 361 | $36K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,655 | $33K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,417 | $32K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 58 | $32K |
| 86780 | <1% | 3,069 | $31K | |
| 97165 | <1% | 814 | $31K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 3,521 | $29K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,835 | $29K |
| 76881 | <1% | 449 | $28K | |
| 70486 | <1% | 998 | $27K | |
| 72100 | <1% | 2,649 | $26K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 27,914 | $26K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 3,426 | $25K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 335 | $24K |
| Q3014 | Telehealth originating site facility fee | <1% | 1,440 | $23K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 252 | $23K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 40,329 | $22K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 2,492 | $22K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 51,548 | $21K |
| 0012A | <1% | 514 | $20K | |
| 0011A | <1% | 529 | $20K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 174 | $20K |
| 82607 | <1% | 3,285 | $17K | |
| 84702 | <1% | 24,422 | $16K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 924 | $16K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 790 | $15K |
| 58558 | <1% | 13 | $15K | |
| 84439 | <1% | 4,032 | $15K | |
| 77065 | Tomosynthesis, mammo | <1% | 315 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 361 | $14K |
| 85027 | <1% | 14,234 | $14K | |
| 93458 | <1% | 12 | $14K | |
| 93976 | <1% | 280 | $14K | |
| 96367 | <1% | 567 | $14K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,638 | $13K |
| 76536 | <1% | 257 | $13K | |
| 77066 | Tomosynthesis, mammo | <1% | 205 | $12K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 797 | $12K |
| 82728 | <1% | 2,093 | $12K | |
| 73562 | <1% | 3,541 | $11K | |
| 71250 | <1% | 180 | $11K | |
| 86803 | <1% | 1,827 | $11K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 819 | $10K |
| 83735 | <1% | 48,562 | $9K | |
| 82270 | <1% | 324 | $9K | |
| 82746 | <1% | 1,572 | $9K | |
| 73630 | <1% | 4,171 | $9K | |
| 87340 | <1% | 2,492 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,286 | $9K |
| 83550 | <1% | 2,159 | $9K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,811 | $9K |
| 85610 | <1% | 19,851 | $9K | |
| 73030 | <1% | 2,795 | $8K | |
| 88342 | <1% | 1,516 | $8K | |
| 29515 | <1% | 115 | $8K | |
| 72131 | <1% | 247 | $8K | |
| 83540 | <1% | 2,315 | $7K | |
| 73610 | <1% | 3,503 | $7K | |
| 87808 | <1% | 784 | $7K | |
| 83880 | <1% | 8,663 | $6K | |
| 70498 | <1% | 1,465 | $6K | |
| 73130 | <1% | 3,767 | $6K | |
| 73502 | <1% | 1,386 | $6K | |
| 74018 | <1% | 964 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 4,800 | $5K |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 565 | $5K |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 67 | $5K |
| 82570 | <1% | 2,307 | $5K | |
| 74022 | <1% | 1,854 | $5K | |
| 86850 | <1% | 8,057 | $4K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 147 | $4K |
| 86140 | <1% | 3,916 | $4K | |
| 86762 | <1% | 1,042 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,349 | $4K |
| 85730 | <1% | 16,997 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,161 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 6,460 | $4K |
| 82105 | <1% | 529 | $4K | |
| 82947 | <1% | 995 | $4K | |
| 0001A | <1% | 105 | $4K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 773 | $4K |
| 73110 | <1% | 2,188 | $4K | |
| 87081 | <1% | 8,004 | $4K | |
| 81025 | <1% | 12,401 | $3K | |
| 82565 | <1% | 949 | $3K | |
| 82248 | <1% | 26,888 | $3K | |
| 86787 | <1% | 867 | $3K | |
| 81001 | <1% | 24,278 | $3K | |
| 71271 | <1% | 53 | $3K | |
| 0002A | <1% | 81 | $3K | |
| 84550 | <1% | 2,598 | $3K | |
| 87634 | <1% | 2,484 | $3K | |
| 86003 | <1% | 40 | $3K | |
| 87631 | <1% | 2,032 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 7,466 | $3K |
| 83615 | <1% | 2,069 | $3K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 223 | $3K |
| 82043 | <1% | 820 | $3K | |
| 87186 | <1% | 2,534 | $2K | |
| 72050 | <1% | 149 | $2K | |
| 90686 | <1% | 142 | $2K | |
| 87210 | <1% | 1,886 | $2K | |
| G0008 | Administration of influenza virus vaccine | <1% | 328 | $2K |
| 82550 | <1% | 3,061 | $2K | |
| 84100 | <1% | 5,726 | $2K | |
| 73080 | <1% | 1,311 | $2K | |
| 84403 | <1% | 140 | $2K | |
| 93017 | <1% | 734 | $2K | |
| 80076 | <1% | 626 | $2K | |
| 86592 | <1% | 120 | $2K | |
| 87077 | <1% | 1,817 | $2K | |
| 85652 | <1% | 2,133 | $2K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 134 | $2K |
| 64400 | <1% | 13 | $2K | |
| 86901 | <1% | 8,139 | $2K | |
| 85007 | <1% | 3,211 | $1K | |
| 72170 | <1% | 880 | $1K | |
| 71101 | <1% | 440 | $1K | |
| 83690 | <1% | 25,978 | $1K | |
| 84156 | <1% | 1,279 | $1K | |
| 83970 | <1% | 76 | $1K | |
| 86039 | <1% | 255 | $1K | |
| 81003 | <1% | 10,103 | $1K | |
| 83655 | <1% | 172 | $1K | |
| 80074 | <1% | 122 | $1K | |
| 73590 | <1% | 1,115 | $1K | |
| 83020 | <1% | 305 | $1K | |
| 93880 | <1% | 26 | $1K | |
| 84481 | <1% | 94 | $1K | |
| 72128 | <1% | 13 | $940.74 | |
| 84450 | <1% | 445 | $889.62 | |
| 76882 | <1% | 37 | $881.57 | |
| 84460 | <1% | 423 | $860.46 | |
| 76820 | <1% | 1,626 | $840.90 | |
| 84484 | <1% | 23,124 | $820.50 | |
| 87420 | <1% | 2,345 | $778.51 | |
| 85651 | <1% | 795 | $729.02 | |
| 85379 | <1% | 6,556 | $710.68 | |
| 87088 | <1% | 845 | $681.72 | |
| 84146 | <1% | 66 | $666.87 | |
| 97116 | <1% | 52 | $649.42 | |
| 80164 | <1% | 483 | $647.35 | |
| 83001 | <1% | 67 | $645.91 | |
| 90658 | <1% | 35 | $619.52 | |
| 82803 | <1% | 7,005 | $569.24 | |
| 73090 | <1% | 982 | $561.30 | |
| 97803 | <1% | 64 | $559.13 | |
| 88142 | <1% | 43 | $556.87 | |
| 72040 | <1% | 78 | $550.89 | |
| 82962 | <1% | 15,214 | $549.13 | |
| 87070 | <1% | 466 | $532.16 | |
| 86480 | <1% | 13 | $502.85 | |
| 72072 | <1% | 56 | $501.16 | |
| 51798 | <1% | 1,029 | $446.57 | |
| 82784 | <1% | 41 | $430.29 | |
| 88341 | <1% | 14 | $426.77 | |
| 86038 | <1% | 57 | $325.81 | |
| 87205 | <1% | 555 | $316.91 | |
| 82140 | <1% | 654 | $315.81 | |
| 82077 | <1% | 4,858 | $293.45 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 491 | $275.60 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 9,987 | $262.11 |
| 89060 | <1% | 147 | $261.82 | |
| 88304 | <1% | 786 | $254.67 | |
| 86160 | <1% | 28 | $231.79 | |
| 83002 | <1% | 26 | $231.25 | |
| 87040 | <1% | 2,757 | $227.06 | |
| 83605 | <1% | 7,968 | $213.74 | |
| 82670 | <1% | 13 | $208.64 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 223 | $199.28 |
| 93296 | <1% | 12 | $198.42 | |
| 29125 | <1% | 541 | $185.16 | |
| 12001 | <1% | 1,293 | $184.51 | |
| 86255 | <1% | 29 | $178.37 | |
| 86308 | <1% | 812 | $171.24 | |
| 85045 | <1% | 138 | $168.83 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 12 | $149.95 |
| 87147 | <1% | 217 | $148.83 | |
| 84153 | <1% | 13 | $140.50 | |
| 84520 | <1% | 88 | $136.34 | |
| 76870 | <1% | 221 | $129.46 | |
| 80143 | <1% | 1,392 | $129.44 | |
| 83721 | <1% | 20 | $129.30 | |
| 84703 | <1% | 9,338 | $123.83 | |
| 84480 | <1% | 13 | $120.62 | |
| J2359 | Injection, olanzapine, 0.5 mg | <1% | 20 | $103.60 |
| 12011 | <1% | 496 | $100.76 | |
| 71100 | <1% | 38 | $99.83 | |
| 85384 | <1% | 27 | $81.52 | |
| 96376 | <1% | 11,965 | $75.00 | |
| 76813 | <1% | 283 | $73.84 | |
| 84165 | <1% | 13 | $67.68 | |
| 80179 | <1% | 1,323 | $58.00 | |
| 73060 | <1% | 131 | $52.20 | |
| 73552 | <1% | 39 | $48.48 | |
| 82010 | <1% | 1,136 | $47.71 | |
| 82150 | <1% | 14 | $42.72 | |
| 70360 | <1% | 12 | $34.12 | |
| 86431 | <1% | 14 | $33.54 | |
| 73140 | <1% | 69 | $33.43 | |
| 85018 | <1% | 45 | $32.03 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 352 | $28.27 |
| 83090 | <1% | 229 | $21.65 | |
| 84145 | <1% | 185 | $17.93 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,436 | $6.77 |
| J1836 | Injection, metronidazole, 10 mg | <1% | 77 | $6.57 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 6,744 | $4.16 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 3,513 | $1.93 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,083 | $1.89 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,177 | $1.56 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 18,068 | $1.48 |
| 90715 | 0% | 957 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 61 | $0.00 |
| C1729 | Catheter, drainage | 0% | 333 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,162 | $0.00 |
| C1758 | Catheter, ureteral | 0% | 392 | $0.00 |
| 99152 | 0% | 182 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 437 | $0.00 |
| 91300 | 0% | 208 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 451 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 83 | $0.00 |
| 93325 | 0% | 39 | $0.00 | |
| 93356 | 0% | 598 | $0.00 | |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 44 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 32 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 358 | $0.00 |
| 90838 | 0% | 13 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 15 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 25 | $0.00 |
| C1765 | Adhesion barrier | 0% | 12 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 25 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 13 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 16 | $0.00 |
| J3490 | Unclassified drugs | 0% | 3,836 | $0.00 |
| 12002 | 0% | 140 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 744 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 9,937 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,730 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 237 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 38 | $0.00 |
| C1769 | Guide wire | 0% | 559 | $0.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 0% | 13 | $0.00 |
| 91301 | 0% | 1,041 | $0.00 | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 0% | 33 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 464 | $0.00 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 0% | 327 | $0.00 |
| 96368 | 0% | 68 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 1,999 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,395 | $0.00 |
| 36410 | 0% | 93 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 79 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 101 | $0.00 |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 0% | 175 | $0.00 |
| 87430 | 0% | 143 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 48 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 44 | $0.00 |
| 80178 | 0% | 14 | $0.00 | |
| 84132 | 0% | 16 | $0.00 | |
| 36416 | 0% | 13 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 40 | $0.00 |
| J1817 | Insulin for administration through dme (i.e., insulin pump) per 50 units | 0% | 164 | $0.00 |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 0% | 40 | $0.00 |
| 96127 | 0% | 19 | $0.00 | |
| 88307 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAMSCHRODER, ROBIN (EVP, CHIEF FIN & BUS DEV OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Henry Ford Health System | Detroit, MI | $334.91M |
| Henry Ford Health ST. John Hospital | Chicago, IL | $159.41M |
| Henry Ford Health Providence Hospital | Novi, MI | $72.76M |
| Henry Ford Health Macomb Oakland Hospital | Warren, MI | $59.25M |
| W.A. Foote Memorial Hospital | Jackson, MI | $41.32M |
| Henry Ford Macomb Hospital Corporation | Clinton Twp, MI | $40.96M |
| Henry Ford Health Genesys Hospital | Grand Blanc, MI | $31.39M |
| Henry Ford Health Macomb Oakland Hospital | Madison Heights, MI | $24.76M |
| Henry Ford Health System | West Bloomfield, MI | $19.27M |
| Henry Ford Health Rochester Hospital | Rochester, MI | $11.98M |
| Henry Ford Health River District Hospital | East China, MI | $4.59M |
| W.A. Foote Memorial Hospital | Jackson, MI | $2.11M |
| Henry Ford Health Providence Hospital | Novi, MI | $255K |
| Henry Ford Health ST. John Hospital | Detroit, MI | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.